학술논문

Randomized phase II adjuvant trial to compare two treatment durations of icotinib (2 years versus 1 year) for stage II-IIIA EGFR-positive lung adenocarcinoma patients (ICOMPARE study)

Document Type

Article

Author

Lv, C.; Wang, R.; Li, S.; Yan, S.; Wang, Y.; Chen, J.; Wang, L.; Liu, Y.; Guo, Z.; Wang, J.; Pei, Y.; Yu, L.; Wu, N.; Lu, F.; Gao, F.; Wang, X.; Han, B.; Zhang, L.; Ma, Y.; Ding, L.; Yuan, X.; Yang, Y.

Source

In ESMO Open August 2023 8(4)

Subject

Thoracic Cancers

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송